36
China’s modified virus therapy shows promise in last-stage cancer trials
A new cancer therapy utilising a genetically modified herpes simplex virus type 1 (HSV-1) offers hope for late-stage patients, especially those resistant to existing immunotherapies.
Representational Image
Discover more from Now World View
Subscribe to get the latest posts sent to your email.